Regen Biopharma Inc Stock Forecast
Red day on Friday for Regen Biopharma Inc stock after losing 2.86%
(Updated on Apr 19, 2024)
The Regen Biopharma Inc stock price fell by -2.86% on the last day (Friday, 19th Apr 2024) from $0.700 to $0.680. During the last trading day the stock fluctuated 7.69% from a day low at $0.650 to a day high of $0.700. The price has fallen in 7 of the last 10 days and is down by -5.56% for this period. Volume has increased on the last day by 999 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 12 thousand shares were bought and sold for approximately $7.93 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.16% during the next 3 months and, with a 90% probability hold a price between $0.384 and $0.505 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RGBP Signals & Forecast
There are mixed signals in the stock today. The Regen Biopharma Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.733. On a fall, the stock will find some support from the short-term average at $0.636. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Regen Biopharma Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 19.76%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for Regen Biopharma Inc stock
Regen Biopharma Inc finds support from accumulated volume at $0.650 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0500 between high and low, or 7.69%. For the last week, the stock has had daily average volatility of 14.19%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RGBP) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Regen Biopharma Inc to open at $0.677, and during the day (based on 14 day Average True Range), to move between $0.564 and $0.796, which gives a possible trading interval of +/-$0.116 (+/-17.00%) up or down from last closing price. If Regen Biopharma Inc takes out the full calculated possible swing range there will be an estimated 34.01% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.650 (4.41%) than the resistance at $0.740 (8.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Regen Biopharma Inc stock A Buy?
Regen Biopharma Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.560 Sell Candidate Unchanged
Predicted Opening Price for Regen Biopharma Inc of Monday, April 22, 2024
| Fair opening price April 22, 2024 | Current price |
|---|---|
| $0.677 ( 0.490%) | $0.680 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RGBP
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.727 | 6.86 % | |
| R2 | 0.708 | 4.05 % | ||
| R1 | 0.696 | 2.32 % | ||
| Current price: | 0.680 | |||
| Support | S1 | 0.658 | -3.30 % | |
| S2 | 0.646 | -5.03 % | ||
| S3 | 0.627 | -7.84 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.83 | 22.65 % | |
| R2 | 0.750 | 10.29 % | ||
| R1 | 0.740 | 8.82 % | ||
| Current price | 0.680 | |||
| Support | S1 | 0.650 | -4.41% | |
| S2 | 0.640 | -5.88% | ||
| S3 | 0.610 | -10.29% |
FAQ
Click here for our free guide on how to buy Regen Biopharma Inc Stock.
